These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28159835)

  • 1. miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis.
    Van Renne N; Roca Suarez AA; Duong FHT; Gondeau C; Calabrese D; Fontaine N; Ababsa A; Bandiera S; Croonenborghs T; Pochet N; De Blasi V; Pessaux P; Piardi T; Sommacale D; Ono A; Chayama K; Fujita M; Nakagawa H; Hoshida Y; Zeisel MB; Heim MH; Baumert TF; Lupberger J
    Gut; 2018 May; 67(5):953-962. PubMed ID: 28159835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
    Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
    J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-135a Modulates Hepatitis C Virus Genome Replication through Downregulation of Host Antiviral Factors.
    Sodroski C; Lowey B; Hertz L; Jake Liang T; Li Q
    Virol Sin; 2019 Apr; 34(2):197-210. PubMed ID: 30456659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
    Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
    PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus suppresses Hepatocyte Nuclear Factor 4 alpha, a key regulator of hepatocellular carcinoma.
    Vallianou I; Dafou D; Vassilaki N; Mavromara P; Hadzopoulou-Cladaras M
    Int J Biochem Cell Biol; 2016 Sep; 78():315-326. PubMed ID: 27477312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.
    Li M; Wang W; Jin R; Zhang T; Li N; Han Q; Wei P; Liu Z
    J Med Virol; 2016 Sep; 88(9):1552-9. PubMed ID: 26889748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA LINC01189 is associated with HCV-hepatocellular carcinoma and regulates cancer cell proliferation and chemoresistance through hsa-miR-155-5p.
    Yao Y; Shu F; Wang F; Wang X; Guo Z; Wang H; Li L; Lv H
    Ann Hepatol; 2021; 22():100269. PubMed ID: 33059056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the oncogenic miR-21-5p promotes HCV replication and steatosis induced by the viral core 3a protein.
    Clément S; Sobolewski C; Gomes D; Rojas A; Goossens N; Conzelmann S; Calo N; Negro F; Foti M
    Liver Int; 2019 Jul; 39(7):1226-1236. PubMed ID: 30938910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Serum Vitamin D, Interleukin 13, and microRNA-135a in Hepatocellular Carcinoma and Treatment Failure in Egyptian HCV-Infected Patients Receiving Direct Antiviral Agents.
    Ali ME; Halby HM; Ali MY; Hassan EA; El-Mokhtar MA; Sayed IM; Thabet MM; Fouad M; El-Ashmawy AM; Mahran ZG
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
    Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of miRNA-30c and miR-203a is associated with hepatitis C virus core protein-induced epithelial-mesenchymal transition in normal hepatocytes and hepatocellular carcinoma cells.
    Liu D; Wu J; Liu M; Yin H; He J; Zhang B
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1215-1221. PubMed ID: 26210453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha.
    Wang B; Hsu SH; Frankel W; Ghoshal K; Jacob ST
    Hepatology; 2012 Jul; 56(1):186-97. PubMed ID: 22318941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development.
    Lupberger J; Croonenborghs T; Roca Suarez AA; Van Renne N; Jühling F; Oudot MA; Virzì A; Bandiera S; Jamey C; Meszaros G; Brumaru D; Mukherji A; Durand SC; Heydmann L; Verrier ER; El Saghire H; Hamdane N; Bartenschlager R; Fereshetian S; Ramberger E; Sinha R; Nabian M; Everaert C; Jovanovic M; Mertins P; Carr SA; Chayama K; Dali-Youcef N; Ricci R; Bardeesy NM; Fujiwara N; Gevaert O; Zeisel MB; Hoshida Y; Pochet N; Baumert TF
    Gastroenterology; 2019 Aug; 157(2):537-551.e9. PubMed ID: 30978357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
    Ura S; Honda M; Yamashita T; Ueda T; Takatori H; Nishino R; Sunakozaka H; Sakai Y; Horimoto K; Kaneko S
    Hepatology; 2009 Apr; 49(4):1098-112. PubMed ID: 19173277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 induces tumor suppressor protein tyrosine phosphatase receptor type D by inhibiting miR-34a to prevent IL-6 signaling overactivation.
    Zhang F; Wang B; Qin T; Wang L; Zhang Q; Lu Y; Song B; Yu X; Li L
    Mol Cell Biochem; 2020 Oct; 473(1-2):1-13. PubMed ID: 32602014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients.
    Elemeery MN; Badr AN; Mohamed MA; Ghareeb DA
    World J Gastroenterol; 2017 Jun; 23(21):3864-3875. PubMed ID: 28638226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.